Medical Statistics for Defensible Clinical Research

A manuscript can include a large patient sample, sophisticated software output, and clinically interesting findings, yet still fail peer review because the statistical plan does not answer the clinical question. Medical statistics is not the final technical step performed after data collection. It is the framework that determines whether a result can be interpreted, reproduced, and defended before an ethics committee, thesis jury, or journal reviewer.

For residents, graduate students, clinicians, and research teams, the central task is not simply selecting a test with a small p-value. It is building a transparent connection between the research question, study design, variable structure, analysis method, and scientific conclusion. That connection is where credible evidence begins.

What Medical Statistics Does in Clinical Research

Medical statistics applies statistical reasoning to questions about health, disease, diagnosis, treatment, prognosis, and health services. It helps researchers distinguish a pattern observed in one dataset from evidence that may reasonably inform a broader clinical population.

A clinical question often appears straightforward: Does a treatment improve pain scores? Is a biomarker associated with mortality? Does a screening test identify disease accurately? Each question, however, requires different outcome definitions, comparison structures, assumptions, and reporting standards. An analysis is appropriate only when it reflects these underlying features.

For example, comparing mean postoperative pain scores between two independent treatment groups may call for a two-sample comparison if the outcome distribution and design support it. Repeated pain measurements from the same patients require an approach that accounts for within-person correlation. If the endpoint is time to recurrence rather than recurrence alone, survival analysis is usually more informative than a simple proportion comparison.

The statistical method is therefore not chosen from a menu at the end of the study. It follows from the clinical question and the way the data were generated.

Start With the Question, Not the Software

A sound analysis plan begins by converting a broad topic into an answerable research question. The study population, exposure or intervention, comparator, outcome, and time frame should be clear. This process prevents a common problem in thesis and article preparation: collecting many variables without defining which finding will serve as the primary evidence.

The primary outcome deserves particular attention. It should be clinically meaningful, measurable with sufficient reliability, and specified before analysis whenever possible. A study may collect laboratory values, symptom scales, imaging findings, and demographic variables, but it cannot treat every measure as the main endpoint without increasing the risk of chance findings.

Secondary and exploratory outcomes are valuable, especially in observational research and early-stage projects. They should be labeled honestly. This distinction helps readers understand whether a result was a planned test of a hypothesis or a finding that needs confirmation in a new sample.

A clear question also guides sample size planning. Sample size is not only a matter of enrolling as many patients as possible. It depends on the expected effect size, outcome variability or event rate, significance level, target power, study design, and anticipated missing data. An underpowered study may fail to detect a clinically relevant difference. An excessively large study may identify trivial differences that have little practical value.

Choosing Methods That Match the Data

Medical datasets commonly contain continuous variables such as blood pressure, categorical variables such as disease status, ordinal scales such as symptom severity, and time-to-event outcomes such as overall survival. The measurement level matters, but it is only one part of method selection.

Researchers must also consider whether groups are independent or matched, whether measurements are repeated, whether confounders need adjustment, and whether the outcome is rare. For a binary outcome, logistic regression may estimate the association between predictors and the odds of an event. For a continuous outcome, linear regression may be appropriate when model assumptions are reasonably met. Cox proportional hazards models are often used for follow-up data when the timing of an event and censoring matter.

No method is automatically superior because it is more advanced. A complex model with weakly measured predictors, too few outcome events, or unexplained assumptions can be less credible than a well-designed analysis using a simpler approach. Conversely, relying only on unadjusted comparisons can be misleading when age, disease severity, comorbidity, or treatment selection influences the observed outcome.

The practical question is: What analysis best estimates the effect or association the study intends to examine, given the design and data limitations? The answer may include descriptive statistics, group comparisons, regression modeling, diagnostic performance analysis, reliability analysis, or survival methods. In many projects, it includes more than one of these components.

Assumptions Are Part of the Result

Statistical output should never be accepted without checking whether the model fits the data. Distributional properties, variance patterns, influential observations, multicollinearity, linearity where relevant, and model-specific assumptions affect interpretation.

For instance, a non-normal distribution does not automatically require abandoning parametric methods, particularly in adequately sized samples. But severe skewness, outliers, or small group sizes may call for transformation, a nonparametric method, or a model designed for the outcome distribution. The decision should be justified by the data and research aim, not by a routine software default.

Missing data require the same discipline. Simply excluding incomplete records can bias estimates when missingness is related to patient characteristics or outcomes. The most suitable strategy depends on why data are missing, how much is missing, and which variables are affected. Transparent reporting of the extent of missing data and the handling approach is essential.

Beyond P-Values: Estimation and Clinical Meaning

A p-value addresses compatibility between the observed data and a statistical null hypothesis under specified assumptions. It does not measure the size of an effect, prove a hypothesis, or determine whether a treatment benefit matters to patients.

This is why medical research should report effect estimates and confidence intervals alongside p-values. A mean difference, odds ratio, risk ratio, hazard ratio, sensitivity, specificity, or correlation coefficient gives the result substantive meaning. The confidence interval communicates precision and shows the range of values reasonably compatible with the data.

Clinical relevance may differ from statistical significance. A small improvement can be statistically significant in a large sample but too limited to influence practice. On the other hand, a clinically promising estimate with a wide confidence interval may indicate that further research is needed rather than that the intervention has no value.

This distinction is especially relevant for publication in indexed journals. Reviewers increasingly expect authors to explain what the estimated effect means in the clinical context, not merely report whether a threshold of p < 0.05 was crossed.

Reporting Medical Statistics for Reviewers and Readers

A statistically correct analysis can lose value if it is poorly reported. Readers need enough detail to understand who was studied, how variables were defined, which analyses were planned, and how conclusions were derived.

Tables should present denominators clearly, identify missing observations, and use summary measures that fit the distribution of the data. Means and standard deviations are useful for approximately symmetric continuous variables; medians and interquartile ranges are often more informative for skewed data. Regression tables should identify adjusted variables, report effect estimates with confidence intervals, and avoid presenting p-values as the only result.

Methods sections should state the software, significance threshold where used, handling of missing data, and relevant assumption checks. More importantly, they should describe the analytic logic. A reviewer should be able to see why a particular model was selected and whether it aligns with the protocol and outcome structure.

Reporting guidelines can provide a useful discipline. The relevant framework depends on the design, such as randomized trials, observational studies, diagnostic accuracy research, systematic reviews, or prediction models. These frameworks do not replace methodological judgment, but they reduce omissions that often delay peer review.

Ethics, Transparency, and Statistical Integrity

Medical statistics has an ethical dimension because analytic decisions can change how patient data are represented and how clinical claims are communicated. Selective outcome reporting, repeated testing until a favorable result appears, post hoc subgroup claims, and unexplained data exclusions can overstate evidence.

Scientific integrity requires researchers to distinguish planned analyses from exploratory work, document data-cleaning decisions, preserve an audit trail, and avoid altering hypotheses after seeing the results. Ethical approval and informed consent are foundational, but responsible analysis continues through data management, interpretation, authorship, and publication.

Independent statistical review can be particularly valuable for studies involving multiple endpoints, limited sample sizes, complex longitudinal data, diagnostic tests, or high-stakes treatment comparisons. At Dekartezyen İstatistik, this support is approached as a research process: aligning the study question, design, analysis, reporting, and publication expectations rather than treating statistics as a detached calculation.

Build Statistical Quality Before Data Collection

The most efficient time to solve an analysis problem is before the first participant is enrolled. A protocol-level review can clarify eligibility criteria, variable definitions, outcome timing, case report forms, sample size, and the planned statistical approach. It can also identify whether a proposed question is feasible within the available population and follow-up period.

When data collection has already started, careful planning remains possible. The key is to assess the dataset honestly: what can be answered reliably, which limitations require cautious language, and which additional analyses are justified. Strong medical research does not claim certainty beyond the data. It makes the clearest defensible statement the design allows, then gives readers a transparent basis for trusting it.